Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval The National Cancer Institute and the Food and Drug Administration (2005) / Chapter Skim
Currently Skimming:
References
References
Pages 56-60
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 56... ...
2002. Oncology drug development: United States Food and Drug Administration perspective.
|
From page 57... ...
2003. End points and United States Food and Drug Administration approval of oncology drugs.
|
From page 58... ...
Food and Drug Administration Role in Oncology Product Development in Chabner, BA and Longo, DL, Cancer Chemotherapy and Biotherapy: Principles and Practice, Fourth Edition, Lippincott Williams and Wilkins, Phila, Pa, 2005 Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JCF, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO.
|
From page 59... ...
:149-154. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, Paull KD.
|
From page 60... ...
1984. Origins and development of chemotherapy research at the National Cancer Institute.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.